CIK 0001411685 · Non-accelerated filer<br>Smaller reporting company
Vistagen Therapeutics, Inc.
Sign in to watch- Ticker
- VTGN
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Mar 31
- Incorporated
- NV
- Entity type
- operating
- EIN
- 205093315
- Phone
- 650-577-3600
- Business address
- 343 ALLERTON AVENUE, SOUTH SAN FRANCISCO, CA, 94080
- Former names
- Excaliber Enterprises, Ltd.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2013-12-20 | Underdown Brian J. Director | Returned to the company · Stock Option (Right to Buy) | −125,000 | 0 | ||
| 2013-12-20 | Underdown Brian J. Director | Grant or award · Stock Option (Right to Buy) | +125,000 | 125,000 | ||
| 2013-12-20 | Underdown Brian J. Director | Returned to the company · Stock Option (Right to Buy) | −50,000 | 0 | ||
| 2013-12-20 | Underdown Brian J. Director | Grant or award · Stock Option (Right to Buy) | +50,000 | 50,000 | ||
| 2013-12-20 | Underdown Brian J. Director | Returned to the company · Warrant for Common Stock | −50,000 | 0 | ||
| 2013-12-20 | Underdown Brian J. Director | Grant or award · Warrant for Common Stock | +50,000 | 50,000 | ||
| 2013-12-20 | SNODGRASS H. RALPH PRES./CHIEF SCIENTIFIC OFFICER | Returned to the company · Stock Option (Right to Buy) | −50,000 | 0 | ||
| 2013-12-20 | SNODGRASS H. RALPH PRES./CHIEF SCIENTIFIC OFFICER | Grant or award · Stock Option (Right to Buy) | +50,000 | 50,000 | ||
| 2013-12-20 | SNODGRASS H. RALPH PRES./CHIEF SCIENTIFIC OFFICER | Returned to the company · Stock Option (Right to Buy) | −25,000 | 0 | ||
| 2013-12-20 | SNODGRASS H. RALPH PRES./CHIEF SCIENTIFIC OFFICER | Grant or award · Stock Option (Right to Buy) | +25,000 | 25,000 | ||
| 2013-12-20 | SNODGRASS H. RALPH PRES./CHIEF SCIENTIFIC OFFICER | Returned to the company · Stock Option (Right to Buy) | −150,000 | 0 | ||
| 2013-12-20 | SNODGRASS H. RALPH PRES./CHIEF SCIENTIFIC OFFICER | Grant or award · Stock Option (Right to Buy) | +150,000 | 150,000 | ||
| 2013-12-20 | SNODGRASS H. RALPH PRES./CHIEF SCIENTIFIC OFFICER | Returned to the company · Stock Option (Right to Buy) | −250,000 | 0 | ||
| 2013-12-20 | SNODGRASS H. RALPH PRES./CHIEF SCIENTIFIC OFFICER | Grant or award · Stock Option (Right to Buy) | +250,000 | 250,000 | ||
| 2013-12-20 | SNODGRASS H. RALPH PRES./CHIEF SCIENTIFIC OFFICER | Returned to the company · Stock Option (Right to Buy) | −100,000 | 0 | ||
| 2013-12-20 | SNODGRASS H. RALPH PRES./CHIEF SCIENTIFIC OFFICER | Grant or award · Stock Option (Right to Buy) | +100,000 | 100,000 | ||
| 2013-12-20 | DOTSON JERROLD DUANE CFO AND SECRETARY | Returned to the company · Stock Option (Right to Buy) | −13,541 | 0 | ||
| 2013-12-20 | DOTSON JERROLD DUANE CFO AND SECRETARY | Grant or award · Stock Option (Right to Buy) | +13,541 | 13,541 | ||
| 2013-12-20 | DOTSON JERROLD DUANE CFO AND SECRETARY | Returned to the company · Stock Option (Right to Buy) | −86,459 | 0 | ||
| 2013-12-20 | DOTSON JERROLD DUANE CFO AND SECRETARY | Grant or award · Stock Option (Right to Buy) | +86,459 | 86,459 |
Page 21 of 28 · 544 trades